Why is Colinz Labs falling/rising?

As of 25-Jun, Colinz Laboratories Ltd is experiencing a decline in its stock price, currently at 47.22, reflecting a decrease of 0.96 or 1.99%. The stock has underperformed its sector by 3.04% today and has been on a consecutive downward trend for the last 16 days, resulting in a significant total return drop of 27.52% during this period. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The company's long-term fundamentals are weak, evidenced by a -2.96% CAGR growth in net sales over the last five years and a poor EBIT to interest ratio of 0.36, which suggests challenges in servicing its debt. Furthermore, the company's return on equity is low at 4.40%, indicating limited profitability per unit of shareholders' funds.
In the broader market context, Colinz Laboratories Ltd has significantly underperformed compared to the Sensex, with a 1-week return of -9.57% against the benchmark's gain of 1.61%. Over the past month, the stock has dropped by 19.97%, while the Sensex has risen by 1.27%. Despite a rise in investor participation, as indicated by a 22.41% increase in delivery volume, the overall market sentiment remains negative due to the company's weak financial performance and high valuation metrics, such as a PEG ratio of 10.6. This combination of factors contributes to the stock's continued decline in price.